The suit alleges defendants issued false statements concerning Aurora business and prospects, resulting in its stock trading at inflated prices. READ MORE: https://finance.yahoo.com/news/robbins-geller-rudman-dowd-llp-224800425.html?.tsrc=rss
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between October 23, 2018 and January 6, 2020, inclusive (the “Class Period”) of the important January 21, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.…
Aurora Cannabis stock has erased a dismal start to the year. Sales of gummies and chocolates have exceeded the company’s expectations. READ MORE: https://finance.yahoo.com/m/3d1abf85-b0d8-327b-829b-8025bf64726a/aurora-cannabis-stock-has.html?.tsrc=rss
If they did so at their historical rate last quarter, S&P 500 earnings per share could end up 0.5% higher than a year ago. Delta (DAL) will have a chance to update investors on its recent performance when it reports fourth-quarter earnings this morning. Aurora Cannabis (ACB) shares have dropped almost 22% since the start of 2020 alone. READ MORE:…
DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aurora Cannabis Inc. READ MORE: https://finance.yahoo.com/news/deadline-next-week-schall-law-203700040.html?.tsrc=rss
Aurora’s stock decline is a reaction to analyst downgrades, and it’s a good time to buy shares given the company’s improving cash flow outlook, an analyst at Cantor Fitzgerald says. READ MORE: https://finance.yahoo.com/m/fef67957-f154-3441-bbf6-bf59bee74d8d/aurora-cannabis-stock-has.html?.tsrc=rss
Hagens Berman has filed a class action Complaint on behalf of investors in Aurora Cannabis Inc. (NYSE: ACB). The firm urges ACB investors who have suffered losses in excess of $500,000 to submit their losses now to learn if they qualify to recover their investment losses. READ MORE: https://finance.yahoo.com/news/hagens-berman-national-trial-attorneys-234400171.html?.tsrc=rss
Aurora Cannabis Inc. stock is set to go to $1, according to two analysts. In a note to clients late Thursday, Piper Sandler analyst Michael Lavery downgraded the cannabis producer to the equivalent of a sell and issued a $1 target price, down from $3. Lavery cited risks related to the balance sheet and weak European Union sales as significant…
(ACB) stock’s struggles continued on Friday after two analysts lowered their ratings, citing concerns about the strength of the pot grower’s balance sheet. Aurora stock (ticker: ACB) is down 22% in the new year and has fallen 74% over the past 12 months. Two separate analysts recently called Aurora’s financial strength into question. READ MORE: https://finance.yahoo.com/m/8393a07e-ae6c-36d3-b55c-31f351ca65f6/aurora-cannabis-stock-falls.html?.tsrc=rss
(Bloomberg) — The chorus of voices warning of risks to Aurora Cannabis Inc.’s balance sheet is growing louder.With a C$360 million loan coming due in August 2021, at least three analysts have cautioned that the pot company may be unable to meet the covenants on that debt.“With balance sheet risks to remain a core investment thesis in 2020 in our…
Licensed producer (LP) Aurora Cannabis Inc.’s stock is set to drop to just $1, according to one analyst. Michael Lavery of Piper Sandler sent a note to clients on Jan. 9, downgrading the Canadian cannabis giant to what amounts to a sell, and lowering the target price from $3 to $1. Lavery noted weak sales in Europe and cash-related risks…
The U.S.-listed shares of Aurora Cannabis Inc. tumbled 7.5% toward a 2 1/2-year low in morning trading Friday, after BofA Securities analyst Christopher Carey turned bearish on the Canada-based cannabis company, citing balance sheet concerns and a lack of visibility “on several fronts.” Post cut his rating to underperform, after being at neutral for the past six months, and slashed…